Diffuse large B-cell lymphoma is a heterogeneous group of diseases with different responses to therapy. Targeting mTOR (mammalian target of rapamycin) offers a new approach to improve the treatment.

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. There are several types of DLBCL, each with their own treatment options. Diffuse large B-cell lymphoma (DLBCL) is ...

Lymphoma is a type of blood cancer that begins in the lymphatic system. Large cell lymphoma is a type of non-Hodgkin lymphoma (NHL). It starts in white blood cells called lymphocytes, which are part ...

These findings from research into diffuse large B cell lymphoma (DLBCL) are based on analyses of human patients and a murine model. The immunosuppressive role of fibroblastic reticular cells (FRCs) in ...

Double Induction Containing Either Two Courses or One Course of High-Dose Cytarabine Plus Mitoxantrone and Postremission Therapy by Either Autologous Stem-Cell Transplantation or by Prolonged ...

Four symptoms may indicate a possible relapse of diffuse large B-cell lymphoma. Learn more about them and when to contact a doctor. A relapse of diffuse large B-cell lymphoma can cause a variety of ...

Lymphatic drainage massage gently targets the lymphatic system just under your skin. While touted as a way to flush toxins, it's mainly used to help with swelling from extra lymph fluid in your ...